Tyler Brown - Markel Corp Managing Investments
| 0JYM Stock | 1,583 22.40 1.44% |
Executive
Tyler Brown is Managing Investments of Markel Corp
| Address | 4521 Highwoods Parkway, Glen Allen, VA, United States, 23060-6148 |
| Phone | 804 747 0136 |
| Web | https://www.markel.com |
Markel Corp Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1405 %, meaning that it generated $0.1405 on every $100 dollars invested by stockholders. Markel Corp's management efficiency ratios could be used to measure how well Markel Corp manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Markel Corp's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 33.5 B in 2024, whereas Other Current Assets are likely to drop slightly above 5.9 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Eckart Pech | CompuGroup Medical AG | 55 | |
| Stefanie Peters | CompuGroup Medical AG | 55 | |
| CIMA CPA | Ondine Biomedical | N/A | |
| Donna Connolly | Deltex Medical Group | N/A | |
| Elaine CPA | Ondine Biomedical | N/A | |
| Matt Ross | Ondine Biomedical | N/A | |
| Claudia Thom | CompuGroup Medical AG | 53 | |
| Angela Teufer | CompuGroup Medical AG | 51 | |
| Patrice Lennon | Dalata Hotel Group | 45 | |
| Angelika Vance | Ondine Biomedical | N/A | |
| Kevin Langridge | Futura Medical | N/A | |
| Michael Franz | CompuGroup Medical AG | N/A | |
| Julia Lykhvar | G5 Entertainment AB | N/A | |
| Oliver Bruzek | CompuGroup Medical AG | N/A | |
| Tony McGuigan | Dalata Hotel Group | N/A | |
| Daniel Pedreschi | PPHE Hotel Group | N/A | |
| Emanuele Mugnani | CompuGroup Medical AG | 54 | |
| Dawn Wynne | Dalata Hotel Group | N/A | |
| Alan Richardson | Advanced Medical Solutions | N/A | |
| William Potter | Futura Medical | 76 | |
| Brian Dowd | Advanced Medical Solutions | N/A | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.033 |
Markel Corp Leadership Team
Elected by the shareholders, the Markel Corp's board of directors comprises two types of representatives: Markel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Markel. The board's role is to monitor Markel Corp's management team and ensure that shareholders' interests are well served. Markel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Markel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeremy CPA, President Engine | ||
| Jeff Lamb, Executive Specialty | ||
| Tyler Brown, Managing Investments | ||
| Richard III, CoCEO Director | ||
| Meade Grandis, Chief Controller | ||
| Michael Heaton, Executive President | ||
| Jennifer Blackwell, Deputy Officer | ||
| Frederick May, Vice Development | ||
| Brian Costanzo, Controller Officer | ||
| Philip Freda, Head Reinsurance | ||
| Richard Grinnan, Chief VP | ||
| Thomas Gayner, CoCEO Director | ||
| Paul Broughton, Managing Marketing | ||
| Wendy Houser, Chief Officer | ||
| Sarah Gavlick, Chief Officer | ||
| Robert Cox, Pres Operations | ||
| Bryan Sanders, Chairman Specialty |
Markel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Markel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 19.76 B | |||
| Shares Outstanding | 13.88 M | |||
| Shares Owned By Insiders | 1.97 % | |||
| Shares Owned By Institutions | 79.34 % | |||
| Price To Sales | 1.39 X | |||
| Revenue | 15.79 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Markel Stock Analysis
When running Markel Corp's price analysis, check to measure Markel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Markel Corp is operating at the current time. Most of Markel Corp's value examination focuses on studying past and present price action to predict the probability of Markel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Markel Corp's price. Additionally, you may evaluate how the addition of Markel Corp to your portfolios can decrease your overall portfolio volatility.